Advertisement

Topics

Mylan CEO Hopes EpiPen Furor Leads To 'Price Transparency'

06:47 EST 1 Dec 2016 | Forbes

The CEO of Mylan, the maker of the life-saving EpiPen device said she hopes the pricing controversy over the life-saving device for allergy sufferers leads to changes in how drugs are priced in the U.S.

Original Article: Mylan CEO Hopes EpiPen Furor Leads To 'Price Transparency'

NEXT ARTICLE

More From BioPortfolio on "Mylan CEO Hopes EpiPen Furor Leads To 'Price Transparency'"

Quick Search
Advertisement
 

Relevant Topic

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...